Fatty acids and neuropsychiatric disorders

Fatty acids and neuropsychiatric disorders

In 1937, after qualifying as a medical doctor and before taking up his appointment as a fellow at Magdalen College, Oxford, Hugh Sinclair visited Herbert Evans, the codiscoverer with Katherine Scott Bishop of vitamin E, and became interested in the possibility that some fatty acid deficiencies might account for the rise in ischaemic heart disease in the Western world [1,2]. In his research lett...

Omega-3 fatty acids and neuropsychiatric disorders.

Epidemiological evidence suggests that dietary consumption of the long chain omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), commonly found in fish or fish oil, may modify the risk for certain neuropsychiatric disorders. As evidence, decreased blood levels of omega-3 fatty acids have been associated with several neuropsychiatric conditions, including Attention De...

Gut Microbiota and Neuropsychiatric Disorders

Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders.

This work provides a systematic review of all published randomised, controlled clinical trials (RCT) investigating the effects of n-3 PUFA intake on the prevention and treatment of non-neurodegenerative neuropsychiatric disorders. Five databases (PubMed, EMBASE, LILACS, CINAHL and The Cochrane Database) were searched for RCT in this area published up to April 2011. The selected studies all invo...

The use of artificial neural networks to study fatty acids in neuropsychiatric disorders

BACKGROUND The range of the fatty acids has been largely investigated in the plasma and erythrocytes of patients suffering from neuropsychiatric disorders. In this paper we investigate, for the first time, whether the study of the platelet fatty acids from such patients may be facilitated by means of artificial neural networks. METHODS Venous blood samples were taken from 84 patients with a D...